Abstract
Economic analyses (i.e., analyses that are concerned primarily with questions of resource allocation) are becoming more common in health care in general and care of cancer patients in particular. The most commonly used measure for the valuation of outcome in such analyses is the QALY (quality-adjusted life-years), which combines qualitative (i.e., quality of life) and quantitative (i.e., survival) aspects of the outcome into one dimension. Using economics (i.e., the discipline) as the mode of thinking to help solve problems of resource allocation in health, this paper describes a framework to evaluate the appropriateness of use of a measure of outcome in the context of an economic evaluation. This framework will be used to critically appraise the use of the QALY measure and of two alternative measures, HYE (healthy years equivalent) and WTP (willingness to pay), in economic evaluations of health care interventions. The paper also describes a practical tool that can be used to measure individuals' WTP in the context of public decision making. This tool involves modifying the decision board, a tool developed (originally in the cancer area) to help clinicians present information to patients. The intent is to show that the use of a theoretically superior measure of outcome need not always be empirically restrictive.
Similar content being viewed by others
References
Arrow KJ (1971) Uncertainty and the welfare economics of medical care. In: Arrow KH (ed) Essays in the theory of risk-bearing. Markham, Chicago, pp 177–219
Bell DE, Farquhar PH (1986) Perspectives on utility theory. Operations Res 34: 179–183
Ben Zion U, Gafni A (1983) Evaluation of public investment in health care: Is the risk irrelevant? J Health Eton 2: 161–165
Bleicbrodt H (1995) QALYs and HYEs: under what conditions are they equivalent? J Health Econ 14: 17–37
Broome J (1993) QALYs. J Publ Econ 50: 149–167
Culyer AJ (1981) Health, economics and health economics. In: VanderGang J, Perlman M (eds) Health, economics and health economics. North-Holland, Amsterdam, pp 3–11
Elit LM, Levine MN, Gafni A, Whelan TJ, Doig G, Streiner DL, Rosen B (1996) Patient's preferences for therapy in advanced epithelial ovarian cancer: development, testing and application of a bedside decision instrument. Gynecol Oncol J 62: 329–335
Evans RG (1984) Strained mercy: the economics of Canadian health care. Butterworths, Toronto
Fishburn PC (1988) Expected utility: an anniversary and a new era. J Risk Uncertainty 1: 267–288
Gafni A (1991) Using willingness-topay as a measure of benefits: what is the relevant question to ask in the context of public decision making about health care programs. Med Care 29: 1246–1252
Gafni A (1996) Proper preference based outcome measures in economic evaluations of pharmaceutical interventions. Med Care (in press)
Gafni A, Birch S (1991) Equity considerations in utility-based measures of health outcome in economic appraisals: an adjustment algorithm. J Health Econ 10: 329–342
Gafni A, Birch S (1995) Preferences for outcomes in economic evaluations: an economic approach to ad dressing economic problems. Soc Sci Med 40: 767–776
Gafni A, Birch S, Mehrez A (1993) Economics, health and health economics: HYEs versus QALYs. J Health Econ 12: 325–339
Johannesson M (1995) The ranking properties of healthy years equivalents and quality adjusted life years under certainty and uncertainty. Int J Technol Assess Health Care 11: 40–48
Kaplan RM, Feeny D, Revicki DA (1993) Methods for assessing relative importance in preference based outcome measure. Qual Life Res 2: 467–475
Labelle RJ, Hurley JE (1992) Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities. J Health Eton 11: 259–277
Levine MN, Gafni A, Markham B, MacFarlane B (1992) A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med 117: 53–58
Machina MJ (1987) Choice under uncertainty: problems solved and unsolved. Econ Perspect 1: 121–154
Mehrez A, Gafni A (1989) Quality adjusted life years, utility theory, and healthy years equivalents. Med Decis Making 9: 142–149
Mehrez A, Gafni A (1991) The healthy years equivalent: how to measure them using the standard gamble approach. Med Decis Malting 11: 140–146
Mishan EJ (1971) Elements of costbenefit analysis. Allen and Unwin, London
Mooney G (1986) Economics, medicine and health care. Wheatsheaf, Brighton
O'Brien B, Gafni A (1995) When do ‘dollars’ make sense? Towards a conceptual framework for contingent valuation studies in health care. Med Decis Making 16: 288–302
Phelps CE (1992) Health economics. Harper Collins, New York
Pliskin JS, Shephard DS, Weinstein MC (1980) Utility functions for life years and health status. Operations Res 28: 206–224
Richardson J (1994) Cost-utility analysis: what should be measured? Soc Sci Med 39: 7–21
Sebban C, Browman G, Gafni A, Norman G, Levine MN, Assouline D, Fiere D (1995) Design and validation of a bedside decision instrument to elicit a patient's preferences concerning allogenic bone marrow transplantation in chronic myeloid leukemia. Am J Hematol 48: 221–227
Torrance GW, Feeny D (1989) Utilities and quality-adjusted life-years. Int J Technol Assess Health Care 3: 559–575
Whelan TJ, Levine MN, Gafni A, Lukka H, Mohide EA, Patel M, Streiner DL (1995) Breast irradiation post lumpectomy: development and evaluation of a decision instrument. J Clin Oncol 13: 847–853
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gafni, A. Alternatives to the QALY measure for economic evaluations. Support Care Cancer 5, 105–111 (1997). https://doi.org/10.1007/BF01262566
Issue Date:
DOI: https://doi.org/10.1007/BF01262566